Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Allied BioScience General Information
Allied BioScience developed proprietary antimicrobial coatings such as SurfaceWise2 that were marketed as providing continuous protection against viruses and bacteria on treated surfaces. The company received emergency EPA authorization during the COVID‑19 pandemic but later faced regulatory action over product claims. Independent studies showed efficacy against several pathogens; however, EPA testing raised concerns about real-world performance under certain conditions.
Contact Information
Primary Industry
Non-Drug Biotech
Corporate Office
Plano/Farmers Branch/Dallas-Fort Worth area, Texas
United States
United States
Drug Pipeline
SurfaceWise2
CommercialKey Partnerships
SOCOMORE (manufacturing partnership for SurfaceWise2), UG2 Partners/RSC Bio Solutions (distribution/service partnerships during pandemic response)
Allied BioScience Funding
No funding data available
To view Allied BioScience's complete valuation and funding history, request access »